
The recent outbreak in Disneyland sheds light on common sources of infection and prevention strategies.

The recent outbreak in Disneyland sheds light on common sources of infection and prevention strategies.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at 6 of these.

In October, we celebrate American Pharmacists Month.

The study found patients who were prescribed antibiotics for dental procedures tended to be older and more likely to receive clindamycin, an antibiotic that is associated with C diff infection.

The investigational regimen may be appropriate for a broad range of HIV-positive patients.

The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.

Top news of the day from across the health care landscape.

Promotion of healthy lifestyle changes are crucial among HIV-positive patients cured of hepatitis C.

This virus is found in tropical and subtropical areas in South America and Africa.

SB239 seeks to reduce the penalty for knowingly exposing sexual partners to HIV to a misdemeanor.

The candidate vaccine is a nonlive, recombinant subunit vaccine to help prevent herpes zoster and its complications, such as postherpetic neuralgia, in adults 50 and older.

Accelerated fibrosis in women with a hepatitis C/HIV co-infection begins as early as pre-menopausal years.

Moist, warm skin provides the ideal environment for dermatophytes—fungi that cause skin infections—to flourish.

Approximately 12,000 customers were affected by the breach.

Findings may lead to new targeted treatment options for HIV infection.

West Virginia University program seeks to combat the spread of infectious diseases via injection drug use.

FilmArray can identify the underlying cause of illnesses within 1 hour of testing.

Hepatitis C elimination program screens more than 45K individuals in first 2 years of launch.

Funding will be spread throughout several mentorship programs for youths with HIV to help navigate adult care.

All drugs are both good and bad. Know both sides of the story.

A Rhode Island independent pharmacy is the first in the country offering on-demand Lyme disease post-exposure prophylaxis.

Pilot project to bring pre-exposure prophylaxis to the Philippines for the first time.

Increased efforts in prevention and treatment for HIV show promise in high-burden regions.

More than half of survey respondents with HIV reported concerns about possible drug-drug interactions.

Top articles of the week from Specialty Pharmacy Times.